Supporting clinical research with an intensive-care database
Crowdsourcing clinical data from some 40,000 patients could vastly improve research and critical-care decisions
Critical care decisions in modern day intensive care units (ICUs) are made every day by doctors who rely on decades of studies and clinical trials to inform them of the most effective treatments for these patients, yet the amount of evidence supporting clinical decisions remains extremely low. A recent study evaluated seven interventions in the ICU and found only one provided actual patient benefit, with the others having no effect or even causing harm.
Critical Care Database
Image courtesy of the MIT Laboratory for Computational Physiology
Thousands of medications and interventions are in regular use in the ICU, with an uncountable number of interactions among them. Further, patient demographics and genetics play a role in what treatments are optimal. Patients have their vital signs and serum blood values monitored frequently, sometimes continuously, and as a result the ICU environment is undeniably complex. The role of the care provider is to synthesize this deluge of data into a useful treatment course, and it is not an easy one.
Paucity of well-curated clinical data is often cited as a key challenge in conducting research. There is a need for a new approach to knowledge generation; one which is efficient and can progress much faster than research has in the past.
Researchers at the MIT Laboratory for Computational Physiology have taken an alternative approach to clinical research by freely releasing ICU data to researchers globally, with a goal of crowdsourcing the knowledge generation process. Thanks to this work, researchers are able to test hypotheses using real data acquired from patients admitted to the Beth Israel Deaconess Medical Center in Boston, Massachusetts.
“One of the biggest challenges in health care research is accessing the data,” says Alistair Johnson, a postdoc at MIT’s Institute for Medical Science and Engineering. “You need ethics approval, assistance from the hospital IT department, technical knowledge, and clinical knowledge. We’ve taken care of all that.”
The database, Medical Information Mart for Intensive Care (MIMIC), houses data on over 40,000 patients admitted ICUs at the Beth Israel Deaconess Medical Center since 2000. The data was de-identified to conform with the Health Insurance Portability and Accountability Act, and interested researchers must sign a data use agreement, promising not to use the data for any unlawful purpose among other guarantees. The data collected include vital signs, medications, laboratory measurements, observations, and notes charted by care providers, fluid balance, procedure codes, diagnostic codes, imaging reports, hospital length of stay, survival data, and more.
In addition to making the data available, the laboratory has created an open code repository to allow researchers to collaboratively develop and reuse analytical code. Tom Pollard, a co-author on the paper, notes that when data and code are shared together, studies becomes completely reproducible, and says that collaboration is the key to advancing knowledge. “Sharing this code and data helps to advance the work of researchers around the world, from early-career students to highly experienced academics. Our belief is that together we can achieve much more than would be possible in closed groups.”
Original publication
Other news from the department science
Most read news
More news from our other portals
Last viewed contents
Aseptika Granted United States Patent for Biomarkers for Respiratory Infection Onset
A new mechanism protects against cancer cell migration and neuron hyperexcitability
Lab901 and Biofortuna to collaborate on automated PCR Dx for HLA and Coeliac disease
Asterion Raises £355k Funding to Progress Novel Therapies for Hormone Related Diseases
Evogene and Zeraim Gedera Salt Tolerant Tomato Collaboration Advances to Second Phase
Heptares granted patents covering stabilised receptor technology in Europe and Japan - Key patent grants protect Heptares’ leading position in GPCR-targeted drug design and discovery
Pevion’s therapeutic Candida vaccine shows robust systemic and mucosal immunogenicity
Covestro and Genomatica produce important chemical raw material using biotechnology - Breakthrough for HMDA, widely-used ingredient, paves the way for more sustainable coatings, apparel, adhesives and plastics
Amarin corporation Appoints Colin W. Stewart as President and Chief Executive Officer
Discovery of quantum vibrations in 'microtubules' corroborates theory of consciousness
